Blog

  • Paula Sherriff – 2016 Parliamentary Question to the Department of Health

    Paula Sherriff – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Paula Sherriff on 2016-04-08.

    To ask the Secretary of State for Health, what assessment he has made of the potential effect of the new junior doctor contract on the recruitment and retention of junior doctors.

    Ben Gummer

    Medicine is an extremely popular career choice and we expect that to continue.

    The new contract for doctors in training will have a positive impact on the working life of doctors and on the training they receive. It introduces stronger safeguards to ensure doctors are not required to work long, unsafe hours, enforced through contractual obligations on employers and external scrutiny of those hours by the Care Quality Commission and the independent Guardian of safe working hours.

  • Mike Kane – 2016 Parliamentary Question to the Department of Health

    Mike Kane – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mike Kane on 2016-04-08.

    To ask the Secretary of State for Health, whether NHS England has placed a requirement on Manchester Mental Health and Social Care Trust to pay off its deficit.

    Alistair Burt

    We are advised that NHS England has placed no such requirements. These are matters for the Manchester Mental Health and Social Care NHS Trust and its commissioners.

    We expect all National Health Service trusts to use their resources wisely and within their statutory responsibilities, while delivering high quality, sustainable services to patients. It is for the local NHS to determine the provision of local health services.

  • Louise Haigh – 2016 Parliamentary Question to the Department of Health

    Louise Haigh – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Louise Haigh on 2016-04-08.

    To ask the Secretary of State for Health, what consideration his Department is giving to the fast tracking for treatment for vocational drivers with obstructive sleep apnoea as part of NICE’s approach to clinical guidelines and quality standards.

    George Freeman

    The National Institute for Health and Care Excellence (NICE) has been asked to develop a clinical guideline and quality standard on sleep disordered breathing (including obstructive sleep apnoea). NICE will develop the scope of the clinical guideline, including the key questions that will be addressed by the guidance, in consultation with stakeholders.

    NICE has advised that there is currently no timetable for developing this guidance.

  • Caroline Lucas – 2016 Parliamentary Question to the Department of Health

    Caroline Lucas – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Caroline Lucas on 2016-04-08.

    To ask the Secretary of State for Health, if he will designate NHS Improvement as a public authority for the purposes of the Freedom of Information Act 2000.

    Ben Gummer

    NHS Improvement is the operational name for an organisation that brings together Monitor and the NHS Trust Development Authority. It is a combination of the continuing statutory functions and legal powers vested in these organisations. Both these bodies are public authorities for the purposes of the Freedom of Information (FOI) Act, and so NHS Improvement will continue to be subject to FOI requirements.

  • Tom Brake – 2016 Parliamentary Question to the Department of Health

    Tom Brake – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Tom Brake on 2016-04-08.

    To ask the Secretary of State for Health, what plans his Department has to work with Muscular Dystrophy UK on increasing access to hydrotherapy pools for people with muscular dystrophy and neuromuscular conditions.

    Jane Ellison

    NHS England continues to work with Muscular Dystrophy UK through the Bridging the Gap Project, which aims to ensure people with neuromuscular conditions, along with their families, play a leading role in the development and commissioning of the services they use.

    NHS England commissions some services for patients with neuromuscular conditions nationally as part of its remit to deliver specialised neurological services. However, the majority of services are provided outside of specialised centres and are the responsibility of clinical commissioning groups to provide, should they deem it clinically appropriate. This includes services such as hydrotherapy.

    In 2012 Muscular Dystrophy UK, working with the Department’s National Institute for Health Research (NIHR) issued a call for research proposals into the clinical effectiveness of hydrotherapy in maintaining physical function in people with Duchenne muscular dystrophy (DMD). The call was made because there is little evidence to support the use of hydrotherapy in relation to DMD and other neuromuscular disorders. The NIHR Health Technology Appraisal programme is now funding a pilot study to look at hydrotherapy for the treatment of DMD, with an evaluation report expected in January 2017.

  • Catherine West – 2016 Parliamentary Question to the Department of Health

    Catherine West – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Catherine West on 2016-04-08.

    To ask the Secretary of State for Health, what steps he is taking to ensure that patients with chronic acute urinary tract infections can access appropriate treatment on the NHS.

    Jane Ellison

    The Department does not determine which treatments should be available for what ailments. National Health Service commissioners are responsible for making decisions on individual treatments on the basis of the available evidence, taking into account guidance from the National Institute for Health and Care Excellence (NICE) where available.

    NICE guidance is always evidence based, assuring us of the latest clinical thinking and research to determine the best treatment for patients.

    The guidelines from NICE for urinary tract infections can be found here:

    https://www.nice.org.uk/guidance/cg171/chapter/1-recommendations

    NHS England published new guidance on 16 November 2015 to help improve the care and experience of people with continence issues. This includes the most up to date evidence to support commissioners and providers. The guidance can be found on NHS England’s website and accessed via the following link:

    https://www.england.nhs.uk/2015/11/16/continence-care/

    “

  • Nigel Adams – 2016 Parliamentary Question to the Department of Health

    Nigel Adams – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nigel Adams on 2016-04-08.

    To ask the Secretary of State for Health, what (a) demographic factors, (b) deprivation level factors and (c) factors of difference in distance from target market forces he took into account when determining the funding allocated for (i) Vale of York CCG, (ii) NHS West Cheshire, (iii) NHS North East Essex, (iv) NHS South Warwickshire, (v) NHS Canterbury and Coastal, (vi) NHS Lincolnshire West and (vii) NHE East Riding of Yorkshire.

    Alistair Burt

    Responsibility for clinical commissioning group (CCG) allocations rests with NHS England and the funding allocated to all CCGs is based on the CCG allocations formula. This is based on advice provided by the Advisory Committee on Resource Allocation (ACRA). ACRA is an independent committee and reports jointly to the Secretary of State for Health (in regard to public health allocations) and NHS England in regard to CCG and primary care allocations. The formula was initially approved by NHS England in 2013 and they have now reviewed and updated the formula for 2016-17 onwards.

    The formula is based on the size of the population of each CCG and adjustments, or weights, per head for relative need for health care services and unavoidable costs between CCGs. The weights per head are based on the following:

    ― need due to age (typically, the more elderly the population, the higher the need per head, all else being equal);

    ― additional need over and above that due to age (this includes measures of health status and a number of proxies for health status such as deprivation);

    ― an adjustment for unmet need and health inequalities;

    ― unavoidable higher costs of delivering health care due to location alone, known as the Market Forces Factor (this reflects that staff, land and building costs are higher in for example London than other parts of the country); and

    ― an adjustment for the higher costs of providing emergency ambulance services in sparsely populated areas, and an adjustment for the higher costs of unavoidably small hospitals with 24 hour accident and emergency services in remote areas.

    The final step of the allocations process is to determine how quickly to move CCGs from their current allocation to the target allocation determined by the formula. The objective is to reduce the ‘distance from target’ so that areas furthest below their target allocation receive the biggest increases. This needs to balance against the need to ensure service stability for those areas above target, and that increases are not so large that resources are not used efficiently. The approach also takes account of the distance from target in each area for primary care and specialised services so that the overall funding position for the area is taken into account.

    NHS England recently published a technical guide to allocations which sets out all the individual factors used in determining the allocation levels. The guide is available here:

    https://www.england.nhs.uk/2016/04/allocations-tech-guide-16-17/#

    “

  • Andrew Bridgen – 2016 Parliamentary Question to the Department of Health

    Andrew Bridgen – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Bridgen on 2016-04-08.

    To ask the Secretary of State for Health, what steps he has taken in response to the findings of the first set of operational data collected by NHS England on wheelchair services; and what steps he is taking to ensure that short-term wheelchair loans are available for people waiting for provision of NHS wheelchairs.

    Alistair Burt

    The national wheelchair services data collection was introduced by NHS England in July 2015 and requires clinical commissioning groups to submit quarterly data on their wheelchair services. Data has so far been published for quarter two and quarter three 2015/16. This is a new collection and therefore does not yet provide an opportunity to draw national or regional comparisons. The vast majority of short term wheelchair loans are provided through charities such as the Red Cross and not via the National Health Service.

  • Tom Pursglove – 2016 Parliamentary Question to the Department of Health

    Tom Pursglove – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Tom Pursglove on 2016-04-08.

    To ask the Secretary of State for Health, what help is available to people with hepatitis C infection from contaminated blood.

    Jane Ellison

    Under the current support arrangements, people infected with hepatitis C through the use of National Health Service blood products are offered a lump sum payment of £20,000 on registering and the option to apply for certain discretionary support: both financial and non-financial. Should they develop “Stage 2” hepatitis C, the later stage of the disease, patients are then offered an additional lump sum of £50,000 and a regular annual payment of £14,749. Those people co-infected with hepatitis C stage 2 and HIV are offered a regular annual payment of £29,498. Currently 595 people are receiving these regular annual payments. In addition, 242 people are receiving regular payments for HIV infection.

    However, the Department is consulting on options for a future support scheme which aims to ensure all of those infected with hepatitis C and registered with the payment schemes would receive regular annual payments, up to £15,000. There are currently 2,424 people with “stage 1” hepatitis C currently registered with the payment schemes who would benefit additionally from this proposed change.

  • Danny Kinahan – 2016 Parliamentary Question to the Department of Health

    Danny Kinahan – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Danny Kinahan on 2016-04-08.

    To ask the Secretary of State for Health, what estimate he has made of the number of e-cigarette users who have (a) resumed smoking and (b) purchased vaping supplies from black market sources.

    Jane Ellison

    The best thing a smoker can do to improve their health is to quit smoking for good.

    The Department recognises that electronic cigarettes (e-cigarettes) can help smokers quit and the evidence indicates that they are considerably less harmful to health than cigarettes.

    This Government has committed to publishing a new tobacco control plan to further reduce the prevalence of smoking in England. The development of this plan is underway and will be published later this year. The new strategy will consider the role of e-cigarettes in further reducing the prevalence of smoking in England. To help inform this element of the strategy the Department has been engaging with e-cigarette experts to ensure that local authorities and Stop Smoking Services are provided with up to date, evidenced based advice on e-cigarettes.

    Whilst the Department has not made a formal assessment of the number of e-cigarette users who have resumed smoking, the evidence suggests that in the short-term, relapse rates are lower in those using e-cigarettes to quit.

    The Department has not made an assessment of the number of e-cigarette users who have purchased vaping supplies from black market sources.